Introduction Endogenous or exogenous (corticosteroid-induced) glucocorticoids (GCs)
excess represents, together with diabetes, the most common cause of secondary …

Introduction Glucocorticoid (GC) induced osteoporosis (GIOP) is the most common form of
secondary osteoporosis. It develops in a dose and time dependent manner, due to a rapid …

The use of glucocorticoids in the treatment of medical disorders can lead to rapid bone loss
and increased risk of fragility fracture. Updated clinical guidelines are needed that …

Introduction: Glucocorticoid-induced osteoporosis (GIOP) is one of the most devastating side-
effects of glucocorticoid (GC) use, as it is associated with an increased fracture risk. The …

INTRODUCTION—Glucocorticoid therapy is associated with an appreciable risk of bone
loss, which is most pronounced in the first few months of use. In addition, glucocorticoids …

Glucocorticoid-induced osteoporosis (GIOP) is one of the most serious adverse effects of
glucocorticoids. Despite guidelines on the management of GIOP, effective medications and …

Glucocorticoid-induced osteoporosis is a leading cause of secondary osteoporosis, one of
the more devastating consequences of glucocorticoid therapy. Bone mineral density …

An excess amount of glucocorticoids represents the primary and most frequent etiological
factor influencing secondary osteoporosis. Patients receiving glucocorticoids, but also those …

Glucocorticoids (GCs) are frequently prescribed for various inflammatory and/or life-
threatening conditions concerning many systems in the body. However, they can provoke …

Glucocorticoids (GCs) are often used for improvement of quality of life, particularly in the
elderly, but long-term GC use may cause harm; bone loss and fractures are among the most …